R. Kent Jr McGaughy - Jun 7, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: Director, 10%+ Owner
Signature: /s/ R. Kent McGaughy, Jr.
Stock symbol: RETA
Transactions as of: Jun 7, 2023
Transactions value $: $119,951
Form type: 4
Date filed: 6/9/2023, 04:30 PM
Previous filing: Apr 4, 2023
Next filing: Jan 10, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right to buy)	Award	$120K	+1.63K		$73.68	1.63K	Jun 7, 2023	Class A common stock	1.63K	$93.61	Direct	F1, F2
transaction	RETA	Stock Option (right to buy)	Award	$0	+4.28K		$0.00	4.28K	Jun 7, 2023	Class A common stock	4.28K	$93.61	Direct	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest in 4 equal installments on September 7, 2023, December 7, 2023, March 7, 2024, and June 5, 2024, subject to continued service through each vesting date.
F2	This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $119,954.